Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Erratum: Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients [Volume 36, Issue 3, September 2017, Pages 282-289].

Jeong HY, Cho HJ, Kim SH, Kim JC, Lee MJ, Yang DH, Lee SY.

Kidney Res Clin Pract. 2018 Jun;37(2):180. doi: 10.23876/j.krcp.2018.37.2.180. Epub 2018 Jun 30.

2.

Obturator hernia in autosomal dominant polycystic kidney disease.

Jung JH, Song JH, Ahn SH.

Kidney Res Clin Pract. 2018 Jun;37(2):178-179. doi: 10.23876/j.krcp.2018.37.2.178. Epub 2018 Jun 30. No abstract available.

3.

A case of microscopic polyangiitis presenting with acute spinal subdural hemorrhage.

Suh WY, Lee EK.

Kidney Res Clin Pract. 2018 Jun;37(2):174-177. doi: 10.23876/j.krcp.2018.37.2.174. Epub 2018 Jun 30.

4.

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients.

Park WY, Kang SS, Jin K, Park SB, Choe M, Han S.

Kidney Res Clin Pract. 2018 Jun;37(2):167-173. doi: 10.23876/j.krcp.2018.37.2.167. Epub 2018 Jun 30.

5.

Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study.

Jin K, Ban TH, Jung JY, Kim AJ, Kim Y, Lee SY, Yang DH, Choi BS, Oh KH, Kim J, Kwon YJ, Choi JW, Kim GH.

Kidney Res Clin Pract. 2018 Jun;37(2):157-166. doi: 10.23876/j.krcp.2018.37.2.157. Epub 2018 Jun 30.

6.

Obesity may be erythropoietin dose-saving in hemodialysis patients.

El-Kannishy GM, Megahed AF, Tawfik MM, El-Said G, Zakaria RT, Mohamed NA, Taha EM, Ammar AA, Abd Eltawab AM, Sayed-Ahmed NA.

Kidney Res Clin Pract. 2018 Jun;37(2):148-156. doi: 10.23876/j.krcp.2018.37.2.148. Epub 2018 Jun 30.

7.

Uremic pruritus and associated factors in hemodialysis patients: A multi-center study.

Ozen N, Cinar FI, Askin D, Mut D.

Kidney Res Clin Pract. 2018 Jun;37(2):138-147. doi: 10.23876/j.krcp.2018.37.2.138. Epub 2018 Jun 30.

8.

Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation.

Shin JH, Kang KW, Kim JG, Lee SJ.

Kidney Res Clin Pract. 2018 Jun;37(2):130-137. doi: 10.23876/j.krcp.2018.37.2.130. Epub 2018 Jun 30.

9.

Epidemiology of continuous renal replacement therapy in Korea: Results from the National Health Insurance Service claims database from 2005 to 2016.

Park S, Lee S, Jo HA, Han K, Kim Y, An JN, Joo KW, Lim CS, Kim YS, Kim H, Kim DK.

Kidney Res Clin Pract. 2018 Jun;37(2):119-129. doi: 10.23876/j.krcp.2018.37.2.119. Epub 2018 Jun 30.

10.

Hemodialysis as a life-sustaining treatment at the end of life.

Shin SJ, Lee JH.

Kidney Res Clin Pract. 2018 Jun;37(2):112-118. doi: 10.23876/j.krcp.2018.37.2.112. Epub 2018 Jun 30.

11.

Pathology identifies glomerular treatment targets in diabetic nephropathy.

Alpers CE, Hudkins KL.

Kidney Res Clin Pract. 2018 Jun;37(2):106-111. doi: 10.23876/j.krcp.2018.37.2.106. Epub 2018 Jun 30. Review.

12.

Atrial fibrillation and chronic kidney disease: A bad combination.

Kiuchi MG.

Kidney Res Clin Pract. 2018 Jun;37(2):103-105. doi: 10.23876/j.krcp.2018.37.2.103. Epub 2018 Jun 30. No abstract available.

13.

Why do we need regional chronic kidney disease-mineral bone disorders guidelines?

Oh HJ, Ryu DR.

Kidney Res Clin Pract. 2018 Jun;37(2):101-102. doi: 10.23876/j.krcp.2018.37.2.101. Epub 2018 Jun 30. No abstract available.

14.

Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78].

Cha RH, Kang SW, Park CW, Cha DR, Na KY, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS.

Kidney Res Clin Pract. 2018 Mar;37(1):98-99. doi: 10.23876/j.krcp.2018.37.1.98. Epub 2018 Mar 31.

15.

Paroxysmal nocturnal hemoglobinuria: Kidney biopsy and magnetic resonance imaging.

Park C, Kim SM, Kim DH, Lee EK.

Kidney Res Clin Pract. 2018 Mar;37(1):96-97. doi: 10.23876/j.krcp.2018.37.1.96. Epub 2018 Mar 31. No abstract available.

16.

Incidentally discovered renal arteriovenous malformation.

Lim JH, Lee SY, Cheon H, Kim YL.

Kidney Res Clin Pract. 2018 Mar;37(1):94-95. doi: 10.23876/j.krcp.2018.37.1.94. Epub 2018 Mar 31. No abstract available.

17.
18.

Use of fludrocortisone for intradialytic hypotension.

Seo Y, Jeung S, Kang SM, Yang WS, Kim H, Kim SB.

Kidney Res Clin Pract. 2018 Mar;37(1):85-88. doi: 10.23876/j.krcp.2018.37.1.85. Epub 2018 Mar 31.

19.

Effectiveness of group cognitive behavioral therapy with mindfulness in end-stage renal disease hemodialysis patients.

Sohn BK, Oh YK, Choi JS, Song J, Lim A, Lee JP, An JN, Choi HJ, Hwang JY, Jung HY, Lee JY, Lim CS.

Kidney Res Clin Pract. 2018 Mar;37(1):77-84. doi: 10.23876/j.krcp.2018.37.1.77. Epub 2018 Mar 31.

20.

Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial.

Lim E, Hyun S, Lee JM, Kim S, Lee MJ, Lee SM, Oh YS, Park I, Shin GT, Kim H, Morisky DE, Jeong JC.

Kidney Res Clin Pract. 2018 Mar;37(1):69-76. doi: 10.23876/j.krcp.2018.37.1.69. Epub 2018 Mar 31.

Supplemental Content

Loading ...
Support Center